We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
19 hedge funds and large institutions have $68.1M invested in ADMA Biologics in 2015 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
46% more funds holding
Funds holding: 13 → 19 (+6)
2% more capital invested
Capital invested by funds: $66.8M → $68.1M (+$1.35M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
19
Holders Change
+6
Holders Change %
+46.15%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
5
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BC
Broadfin Capital
New York
|
+$5.79M |
| 2 |
PC
PointState Capital
New York
|
+$2.05M |
| 3 |
JGC
J. Goldman & Co
New York
|
+$1.22M |
| 4 |
CCM
Consonance Capital Management
New York
|
+$1.1M |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
+$535K |
Top Sellers
| 1 |
SCM
Sio Capital Management
New York
|
-$2.75M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$26.6K |
| 3 |
US Bancorp
Minneapolis,
Minnesota
|
-$22K |
| 4 |
PCM
Prelude Capital Management
New York
|
-$6.05K |
| 5 |
RC
RegentAtlantic Capital
Morristown,
New Jersey
|
-$5.58K |
